Ping Cheung Lam
Vorsitzender bei MINGYUAN MEDICARE DEVELOPMENT CO., LTD.
Aktive Positionen von Ping Cheung Lam
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MINGYUAN MEDICARE DEVELOPMENT CO., LTD. | Vorsitzender | 20.05.2016 | - |
Karriereverlauf von Ping Cheung Lam
Ehemalige bekannte Positionen von Ping Cheung Lam
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
OSHIDORI INTERNATIONAL HOLDINGS LIMITED | Direktor/Vorstandsmitglied | 27.03.2012 | 21.05.2015 |
Independent Dir/Board Member | 27.03.2012 | 21.05.2015 | |
GOLDEN RESOURCES DEVELOPMENT INTERNATIONAL LIMITED | Direktor/Vorstandsmitglied | 13.10.2011 | 30.08.2012 |
Independent Dir/Board Member | 13.10.2011 | 30.08.2012 | |
SEAMLESS GREEN CHINA (HOLDINGS) LIMITED | Direktor/Vorstandsmitglied | 01.01.2010 | 04.08.2011 |
C C LAND HOLDINGS LIMITED | Direktor/Vorstandsmitglied | - | 22.06.2006 |
Lam & Co. (Hong Kong) | Gründer | - | - |
Corporate Officer/Principal | - | - |
Ausbildung von Ping Cheung Lam
The Chinese University of Hong Kong | Undergraduate Degree |
Statistik
International
Hong Kong | 8 |
Operativ
Director/Board Member | 4 |
Independent Dir/Board Member | 2 |
Undergraduate Degree | 1 |
Sektoral
Finance | 3 |
Electronic Technology | 2 |
Retail Trade | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
SEAMLESS GREEN CHINA (HOLDINGS) LIMITED | Electronic Technology |
GOLDEN RESOURCES DEVELOPMENT INTERNATIONAL LIMITED | Retail Trade |
OSHIDORI INTERNATIONAL HOLDINGS LIMITED | Finance |
C C LAND HOLDINGS LIMITED | Finance |
Private Unternehmen | 2 |
---|---|
Mingyuan Medicare Development Co. Ltd.
Mingyuan Medicare Development Co. Ltd. BiotechnologyHealth Technology Mingyuan Medicare Development Co. Ltd. engages in provision of medicare solutions for the early detection and prevention of diseases particularly in China. It operates through the following segments: Protein Chips, Healthcare, Medical Centers Management, Individualized Target Therapy, and Bio-Drugs. The Protein Chips segment manufactures and distributes C-12 products to hospitals, medical centers, and life insurance companies in China. The Healthcare segment engages in the provision of sales and marketing campaign for HPV DNA testing kits and making important progress to register products for distribution to female patients at hospitals nationwide. The Medical Centers Management segment engages in the provision of healthcare services for residents living in cities. The Individualized Target Therapy segment specializes in molecular diagnostic kits for leukemia, lymphoma and individualised target cancer therapy. The Bio-Drugs segment engages in the development, production and commercialization of a new generation of non-specific nanotechnology immunomodulatory drugs known as non-cell Corynebacterium pavum products. The company was founded on May 8, 1989 and is headquartered in Hong Kong. | Health Technology |
Lam & Co. (Hong Kong) |
- Börse
- Insiders
- Ping Cheung Lam
- Erfahrung